Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi

IBSE:ONCSM Stock Report

Market Cap: ₺2.5b

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi Dividends and Buybacks

Dividend criteria checks 1/6

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi is a dividend paying company with a current yield of 0.4%.

Key information

0.4%

Dividend yield

1.5%

Buyback Yield

Total Shareholder Yield1.9%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per share₺0.415
Payout ratio-9%

Recent dividend and buyback updates

No updates

Recent updates

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Too early to tell whether ONCSM's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if ONCSM's dividend payments are increasing as they only just started paying a dividend.

Dividend Yield vs Market

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi Dividend Yield vs Market
How does ONCSM dividend yield compare to the market?
SegmentDividend Yield
Company (ONCSM)0.4%
Market Bottom 25% (TR)0.5%
Market Top 25% (TR)2.6%
Industry Average (Medical Equipment)1.5%
Analyst forecast (ONCSM) (up to 3 years)n/a

Notable Dividend: ONCSM's dividend (0.4%) isn’t notable compared to the bottom 25% of dividend payers in the TR market (0.48%).

High Dividend: ONCSM's dividend (0.4%) is low compared to the top 25% of dividend payers in the TR market (2.59%).

Earnings Payout to Shareholders

Earnings Coverage: ONCSM is paying a dividend but the company is unprofitable.

Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (32.6%), ONCSM's dividend payments are well covered by cash flows.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 06:46
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution